Putting the Patient First: What Matters Most to Patients in the Diagnosis and Management of Axial Spondyloarthritis
Although there is anecdotal evidence of patient experiences in using axial SpA services, there has not been any significant quantitative assessment of patient values and needs in axial SpA services. National and international guidelines are based on a predominantly clinical view of services. The study therefore aims to provide a critical counter-balance to the clinical perspective.
The deadline for applications is 21 June 2021. To register their expression of interest and for an informal discussion with Dr Dale Webb, CEO NASS, potential applicants should contact firstname.lastname@example.org and cc email@example.com.
Uncovering the Cost of Misdiagnosis
NASS is about to embark upon a pioneering piece of research to establish the true impact that delayed axial SpA diagnosis has on the individual, the NHS, the economy and society.
This is a highly specialist field requiring health economics experts who have modelling capability and the ability to freely access all the relevant databases required to undertake the work. If you, or someone you know, might be interested in applying to lead this research you can read more about the opportunity here.
The deadline for applications is 31 May 2021. To register their expression of interest and for an informal discussion with Dr Dale Webb potential applicants should contact us via firstname.lastname@example.org in the first instance.